<SEC-DOCUMENT>0000929638-25-000041.txt : 20250106
<SEC-HEADER>0000929638-25-000041.hdr.sgml : 20250106
<ACCEPTANCE-DATETIME>20250106170539
ACCESSION NUMBER:		0000929638-25-000041
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250106

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PSYENCE BIOMEDICAL LTD.
		CENTRAL INDEX KEY:			0001985062
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94325
		FILM NUMBER:		25512198

	BUSINESS ADDRESS:	
		STREET 1:		121 RICHMOND STREET WEST PENTHOUSE
		STREET 2:		SUITE 1300
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5H 2K1
		BUSINESS PHONE:		27744604171

	MAIL ADDRESS:	
		STREET 1:		121 RICHMOND STREET WEST PENTHOUSE
		STREET 2:		SUITE 1300
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5H 2K1

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AdvisorShares Trust
		CENTRAL INDEX KEY:			0001408970
		ORGANIZATION NAME:           	
		IRS NUMBER:				260636087
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		4800 MONTGOMERY LANE
		STREET 2:		SUITE 150
		CITY:			BETHESDA
		STATE:			MD
		ZIP:			20814
		BUSINESS PHONE:		(877) 843-3831

	MAIL ADDRESS:	
		STREET 1:		4800 MONTGOMERY LANE
		STREET 2:		SUITE 150
		CITY:			BETHESDA
		STATE:			MD
		ZIP:			20814
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>SCHEDULE 13G/A</submissionType>
<previousAccessionNumber>0000929638-24-003819</previousAccessionNumber>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001408970</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>



</filerInfo>
</headerData>
<formData>
<coverPageHeader>
<amendmentNo>1</amendmentNo>
<securitiesClassTitle>Common Shares, no par value</securitiesClassTitle>
<eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
<issuerInfo>
<issuerCik>0001985062</issuerCik>
<issuerName>PSYENCE BIOMEDICAL LTD.</issuerName>
<issuerCusip>74449F209</issuerCusip>
<issuerPrincipalExecutiveOfficeAddress>
<com:street1>121 RICHMOND STREET WEST PENTHOUSE</com:street1>
<com:street2>SUITE 1300</com:street2>
<com:city>TORONTO</com:city>
<com:stateOrCountry>A6</com:stateOrCountry>
<com:zipCode>M5H 2K1</com:zipCode>
</issuerPrincipalExecutiveOfficeAddress>
</issuerInfo>
<designateRulesPursuantThisScheduleFiled>
<designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
</designateRulesPursuantThisScheduleFiled>
</coverPageHeader>
<coverPageHeaderReportingPersonDetails>

<reportingPersonName>AdvisorShares Trust</reportingPersonName>
<citizenshipOrOrganization>DE</citizenshipOrOrganization>
<reportingPersonBeneficiallyOwnedNumberOfShares>
<soleVotingPower>26923.75</soleVotingPower>
<sharedVotingPower>0</sharedVotingPower>
<soleDispositivePower>26923.75</soleDispositivePower>
<sharedDispositivePower>0</sharedDispositivePower>
</reportingPersonBeneficiallyOwnedNumberOfShares>
<reportingPersonBeneficiallyOwnedAggregateNumberOfShares>26923.75</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
<aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
<classPercent>0.79</classPercent>
<typeOfReportingPerson>IV</typeOfReportingPerson>
</coverPageHeaderReportingPersonDetails>
<items>
<item1>
<issuerName>PSYENCE BIOMEDICAL LTD.</issuerName>
<issuerPrincipalExecutiveOfficeAddress>121 RICHMOND STREET WEST PENTHOUSE, SUITE 1300, TORONTO, Ontario, Canada, M5H 2K1</issuerPrincipalExecutiveOfficeAddress>
</item1>
<item2>
<filingPersonName>AdvisorShares Trust</filingPersonName>
<principalBusinessOfficeOrResidenceAddress>4800 Montgomery Lane, Suite 150&#13;
Bethesda, Maryland 20814</principalBusinessOfficeOrResidenceAddress>
<citizenship>Delaware</citizenship>
</item2>
<item3>
<notApplicableFlag>N</notApplicableFlag>
<typeOfPersonFiling>IV</typeOfPersonFiling>
</item3>
<item4>
<amountBeneficiallyOwned>26,923.75</amountBeneficiallyOwned>
<classPercent>0.79</classPercent>
<numberOfSharesPersonHas>
<solePowerOrDirectToVote>26,923.75</solePowerOrDirectToVote>
<sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
<solePowerOrDirectToDispose>26,923.75</solePowerOrDirectToDispose>
<sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
</numberOfSharesPersonHas>
</item4>
<item5>
<notApplicableFlag>N</notApplicableFlag>
<classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
</item5>
<item6>
<notApplicableFlag>Y</notApplicableFlag>
</item6>
<item7>
<notApplicableFlag>Y</notApplicableFlag>
</item7>
<item8>
<notApplicableFlag>Y</notApplicableFlag>
</item8>
<item9>
<notApplicableFlag>Y</notApplicableFlag>
</item9>
<item10>
<notApplicableFlag>N</notApplicableFlag>
<certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
</item10>
</items>
<signatureInformation>
<reportingPersonName>AdvisorShares Trust</reportingPersonName>
<signatureDetails>
<signature>/s/ Stefanie Little</signature>
<title>Stefanie Little - Chief Compliance Officer</title>
<date>01/06/2025</date>
</signatureDetails>
</signatureInformation>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
